Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy and safety of alogliptin, once daily
(QD) combined with a thiazolidine taken QD in type 2 diabetic patients with uncontrolled
blood glucose.